Clinical Trial

Investigation of Pain Modulation Phenotypes in Female Patients With Fibromyalgia

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Fibromyalgia is characterized by altered pain processing, including impaired descending pain inhibition and central sensitization. While both mechanisms have been independently associated with disease severity, their interrelationship remains unclear. This cross-sectional study aims to investigate whether central sensitization symptoms mediate the relationship between conditioned pain modulation and fibromyalgia impact.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-05.
Trial Details
NCT Number NCT07640607
Lead Sponsor Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
Conditions Fibromyalgia (FM), Quantitative Sensory Testing, Central Sensitization, PRESSURE PAIN THRESHOLD, Pain Perception
Enrollment 82 participants
Start Date 2026-07-01
Primary Completion 2026-08-30 (estimated)
Study Completion 2026-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-07